Comments to FDA: Significant Scientific Agreement Share page: Docket Number: 99D-5424 CHPA submits these written comments in response to FDA’s notice in the Federal Register concerning “Guidance for Industry: Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplements.” Download Document Issues: Dietary Supplements Other Issues Research Related Posts Press Releases and Statements CHPA Statement on Senate Confirmation of Dr. Makary as FDA Commissioner Mar 25, 2025 Press Releases and Statements CHPA Expresses Serious Disappointment and Concern for Consumers Over New Law in West Virginia Banning Certain Additives in Dietary Supplements Mar 25, 2025 Press Releases and Statements CHPA Comments on News of Dismissals & Layoffs at FDA Feb 18, 2025